Citadel Securities LLC recently announced the acquisition of new stake in Intelligent Bio Solutions Inc. (NASDAQ:INBS). This fresh investment now brings its stake to 0.19% valued currently at $6915.0. In addition, Strategic Advisers LLC raised its holdings by 10000.0 to 10000.0 shares.
With over 146.28 million Intelligent Bio Solutions Inc. (INBS) shares trading Monday and a closing price of $1.03 on the day, the dollar volume was approximately $150.66 million. The shares have shown a positive half year performance of 41.37% and its price on 01/23/23 gained nearly 293.13%. Currently, there are 14.89M common shares owned by the public and among those 14.74M shares have been available to trade.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for INBS have a consensus price objective of $1.60. The analysts have set the share’s price value over the next 12 months at a high of $1.60 and a low of $1.60. The average price target is 35.62% above its recent price level and an upside to the estimated low will see the stock gain 35.62% over that period. But an upside of 35.62% will see the stock hit the forecast high price target while median target price for the stock is $1.60.
Insiders at the company have transacted a total of 20 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, accounting for 310,970 shares. Insider sales of the common stock occurred on 11 occasions, with total insider shares sold totaling 1,100,000 shares.
The top 3 mutual fund holders in Intelligent Bio Solutions Inc. are Fidelity Extended Market Index Fu, Vanguard Extended Market Index Fu, and Vanguard Invt. Fds. ICVC – US Equ. Fidelity Extended Market Index Fu owns 0.11 million shares of the company’s stock, all valued at over $22325.0. Vanguard Extended Market Index Fu bought 462.0 shares to see its total holdings expand to 11850.0 shares valued at over $2370.0 and representing 0.07% of the shares outstanding. Vanguard Invt. Fds. ICVC – US Equ now owns shares totaling to 0.03% of the shares outstanding.
Shares of Intelligent Bio Solutions Inc. (NASDAQ: INBS) opened at $1.00, up $0.74 from a prior closing price of $0.26. However, the script later moved the day high at 1.6000, up 293.13%. The company’s stock has a 5-day price change of 268.25% and 118.22% over the past three months. INBS shares are trading 415.26% year to date (YTD), with the 12-month market performance down to -33.55% lower. It has a 12-month low price of $0.17 and touched a high of $1.54 over the same period. INBS has an average intraday trading volume of 54.42K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 317.10%, 221.54%, and 86.73% respectively.
Institutional ownership of Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares accounts for 1.90% of the company’s 14.89M shares outstanding. Mutual fund holders own 1.15%, while other institutional holders and individual stakeholders account for 9.44% and 0.70% respectively.
It has a market capitalization of $18.09M. The earnings-per-share (ttm) stands at -$0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 24.29% over the week and 19.18% over the month.
Analysts forecast that Intelligent Bio Solutions Inc. (INBS) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and -$0.09 for 2024. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Earnings per share for the fiscal year are expected to increase by 16.20%, and 53.10% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Intelligent Bio Solutions Inc. (INBS) as a “Strong Buy” at a consensus score of 1.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
